Education Qualifications: MBBS (Singapore), MRCP (UK), PhD (Sweden)
Dr Tan received his basic medical degree from the National University of Singapore and continued his postgraduate Internal Medicine training in Singapore. He obtained membership from the Royal College of Physicians (UK) in 2001. He qualified in the specialty of Infectious Disease in 2004 and earned a PhD in Microbiology from Lund University, Sweden in 2007. He became Head of the Department of Infectious Diseases Department in SGH in 2014. His clinical and research interest is in infections in immunocompromised hosts. He has received funding for research from Singapore’s NMRC and other agencies. He has served as advisory board member to several pharmaceutical companies in the past. He has co-authored more than 60 peer-reviewed manuscripts to date. He is currently a Co-director at the SingHealth-Duke NUS Infectious Disease Research Institute (IDRI) and is the Vice Chair, Clinical Service Improvement & Innovation in Medicine Academic Clinical Programme.
Professional Appointments and Committee Memberships:
- Head & Senior Consultant, Department of Infectious Diseases, Singapore General Hospital
- Chair of JCST Exit Examination Committee
- Member RAC committee (Infectious Diseases)
- Academic Vice-Chair, Clinical Service Improvement & Innovation, Medicine ACP
Awards:
- Safety Star Award, Singapore General Hospital, 2019
- Singapore General Hospital 20 years Long Service Award, 2018
- Outstanding Faculty Award – SingHealth Residency, 2015.
- Singapore Health Quality Service Star Award (SHQSA), 2013
- The Annals Gold Reviewer Award, 2010
- Service Quality Award Winner – Oct 2009, 2011
- EXSA Silver award, 2008
- Singapore Medical Journal best reviewer award, 2008
- International Immunocompromised Host Society Meeting Award, 2004
- Award from the Royal Physiographic Society of Lund University, 2005
- Special SARS recognition Award, SingHealth, July 2003
Leadership positions / roles in Education:
- Programme Director, SingHealth’s Infectious Disease Senior Residency Programme, 2012
Research Interests: His clinical and research interest is in infections in immunocompromised hosts.
Selected Publications:
Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.Teo JQ, Chang CW, Leck H, Tang CY, Lee SJ, Cai Y, Ong RT, Koh TH, Tan TT, Kwa AL. Int J Antimicrob Agents. 2019 May;53(5):657-662.
Staphylococcal driveline infections are the predominant type of left ventricular assist device associated infections in Singapore. Teh YE, Lim CP, Teo LLY, Soon JL, Chao VTT, Neo CL, Tan JLL, Kerk KL, Sim DKL, Tan TE, Tan BH, Cumaraswamy S, Tan TT.Infect Dis (Lond). 2019 Jun;51(6):417-424.
Subtherapeutic posaconazole troughs despite high-dose posaconazole tablets in a patient with terminal ileum resection. Zhou PY, Lim TP, Tang SLS, Lee HLW, Tan TT, Tan BH, Tan SYM, Wong GC, Kwa LHA.J Infect. 2019 May;78(5):409-421.
Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant.Guo Y, Tan EK, Krishnamoorthy TL, Tan CK, Tan BH, Tan TT, Lee SY, Chan CY, Cheow PC, Chung AYF, Jeyaraj PR, Goh BKP.Ann Hepatobiliary Pancreat Surg. 2019 Feb;23(1):1-7.
Rapid Antibiotic Combination Testing for Carbapenem-Resistant Gram-Negative Bacteria within Six Hours Using ATP Bioluminescence. Cai Y, Seah CL, Leck H, Lim TP, Teo JQ, Lee W, Tan TT, Koh TH, Ee PLR, Kwa AL. Antimicrob Agents Chemother. 2018 Aug 27;62(9).